Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Rating) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 1,580,000 shares, an increase of 23.4% from the April 30th total of 1,280,000 shares. Based on an average daily volume of 223,800 shares, the short-interest ratio […]
Treace Medical Concepts, Inc. (NASDAQ:TMCI – Get Rating) Director James T. Treace sold 30,313 shares of the company’s stock in a transaction that occurred on Wednesday, May 25th. The stock was sold at an average price of $15.35, for a total value of $465,304.55. Following the transaction, the director now directly owns 1,356,128 shares of […]
Treace Medical Concepts (NASDAQ:TMCI – Get Rating) and PolyPid (NASDAQ:PYPD – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitability and earnings. Institutional and Insider Ownership 38.8% of Treace Medical Concepts […]
Treace Medical Concepts (NASDAQ:TMCI – Get Rating) is one of 213 public companies in the “Surgical & medical instruments” industry, but how does it contrast to its competitors? We will compare Treace Medical Concepts to related businesses based on the strength of its analyst recommendations, earnings, valuation, risk, profitability, dividends and institutional ownership. Valuation & […]
CVR Medical (OTCMKTS:CRRVF – Get Rating) and Treace Medical Concepts (NASDAQ:TMCI – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, valuation, institutional ownership and analyst recommendations. Analyst Ratings This is a summary of recent […]